These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23429058)

  • 1. Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential.
    Mahon CM; Lambert MA; Glanville J; Wade JM; Fennell BJ; Krebs MR; Armellino D; Yang S; Liu X; O'Sullivan CM; Autin B; Oficjalska K; Bloom L; Paulsen J; Gill D; Damelin M; Cunningham O; Finlay WJ
    J Mol Biol; 2013 May; 425(10):1712-30. PubMed ID: 23429058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.
    Fellouse FA; Esaki K; Birtalan S; Raptis D; Cancasci VJ; Koide A; Jhurani P; Vasser M; Wiesmann C; Kossiakoff AA; Koide S; Sidhu SS
    J Mol Biol; 2007 Nov; 373(4):924-40. PubMed ID: 17825836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and analysis of the improved human HAL9/10 antibody phage display libraries.
    Kügler J; Wilke S; Meier D; Tomszak F; Frenzel A; Schirrmann T; Dübel S; Garritsen H; Hock B; Toleikis L; Schütte M; Hust M
    BMC Biotechnol; 2015 Feb; 15():10. PubMed ID: 25888378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combinatorial mutagenesis with alternative CDR-L1 and -H2 loop lengths contributes to affinity maturation of antibodies.
    Brockmann EC; Pyykkö M; Hannula H; Khan K; Lamminmäki U; Huovinen T
    N Biotechnol; 2021 Jan; 60():173-182. PubMed ID: 33039698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
    Almagro JC; Raghunathan G; Beil E; Janecki DJ; Chen Q; Dinh T; LaCombe A; Connor J; Ware M; Kim PH; Swanson RV; Fransson J
    J Mol Recognit; 2012 Mar; 25(3):125-35. PubMed ID: 22407976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a scFv Library with Synthetic, Non-combinatorial CDR Diversity.
    Bai X; Shim H
    Methods Mol Biol; 2017; 1575():15-29. PubMed ID: 28255872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity.
    Bai X; Kim J; Kang S; Kim W; Shim H
    PLoS One; 2015; 10(10):e0141045. PubMed ID: 26484868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.
    Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel heavy domain antibody library with functionally optimized complementarity determining regions.
    Mandrup OA; Friis NA; Lykkemark S; Just J; Kristensen P
    PLoS One; 2013; 8(10):e76834. PubMed ID: 24116173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions.
    Maruthachalam BV; El-Sayed A; Liu J; Sutherland AR; Hill W; Alam MK; Pastushok L; Fonge H; Barreto K; Geyer CR
    Chembiochem; 2017 Nov; 18(22):2247-2259. PubMed ID: 28884521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures.
    Zemlin M; Klinger M; Link J; Zemlin C; Bauer K; Engler JA; Schroeder HW; Kirkham PM
    J Mol Biol; 2003 Dec; 334(4):733-49. PubMed ID: 14636599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platform for high-throughput antibody selection using synthetically-designed antibody libraries.
    Batonick M; Holland EG; Busygina V; Alderman D; Kay BK; Weiner MP; Kiss MM
    N Biotechnol; 2016 Sep; 33(5 Pt A):565-73. PubMed ID: 26607994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
    Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery.
    Valadon P; Pérez-Tapia SM; Nelson RS; Guzmán-Bringas OU; Arrieta-Oliva HI; Gómez-Castellano KM; Pohl MA; Almagro JC
    MAbs; 2019 Apr; 11(3):516-531. PubMed ID: 30663541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of Heavy Complementarity Determining Region 3 (CDR-H3) Residues Can Synergistically Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen.
    Moon SK; Park SR; Park A; Oh HM; Shin HJ; Jeon EJ; Kim S; Park HJ; Yeon YJ; Yoo YJ
    Mol Cells; 2016 Mar; 39(3):217-28. PubMed ID: 26743905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.